|
HCQ Success in Senegal
[CGTN] Regarding the treatment of COVID-19 patients, the official said the convincing results of the use of the combination of hydroxychloroquine and azithromycin were confirmed.Professor Moussa Seydi, head of the infectious diseases department at Fann hospital, said this combination will be continued in Senegal. "Currently, the analysis of our data collected from 838 patients. The results that we have obtained on the use of hydroxychloroquine and azithromycin have confirmed the efficiency of this combination," he said. According to him, the median hospital stay is 10 days among patients who were under hydroxychloroquine and azithromycin, and 12 for those who weren't. "It is a well tolerated treatment, the side effects rate is between 2 and 3 percent. All the patients who took this treatment at an early stage of the disease did not have any complications and no one died," Seydi said. Posted by: KBK 2020-07-04 |
| http://www.rantburg.com/poparticle.php?ID=576029 |